|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-10-4
|
|
pubmed:abstractText |
Although the duration and amount of cigarette smoking correlate with reduction in pulmonary function, there is still variation among individual responses. IL-13 is involved in pulmonary inflammation, remodeling, and susceptibility to chronic obstructive pulmonary disease (COPD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1073-449X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
176
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
748-52
|
|
pubmed:dateRevised |
2009-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17615386-Adult,
pubmed-meshheading:17615386-Aged,
pubmed-meshheading:17615386-Aged, 80 and over,
pubmed-meshheading:17615386-Female,
pubmed-meshheading:17615386-Forced Expiratory Volume,
pubmed-meshheading:17615386-Genotype,
pubmed-meshheading:17615386-Heterozygote,
pubmed-meshheading:17615386-Homozygote,
pubmed-meshheading:17615386-Humans,
pubmed-meshheading:17615386-Interleukin-13,
pubmed-meshheading:17615386-Logistic Models,
pubmed-meshheading:17615386-Male,
pubmed-meshheading:17615386-Middle Aged,
pubmed-meshheading:17615386-Polymorphism, Single Nucleotide,
pubmed-meshheading:17615386-Promoter Regions, Genetic,
pubmed-meshheading:17615386-Smoking,
pubmed-meshheading:17615386-Vital Capacity
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function.
|
|
pubmed:affiliation |
Center for Human Genomics and Department of Medicine, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA. asadeghn@wfubmc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
